Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elliott Management
Pharma
BioMarin settles with Elliott, adds new directors, review committee
Elliott Investment Management is one of BioMarin's largest investors with a stake worth more than $1 billion.
Zoey Becker
Dec 21, 2023 10:50am
Activist investor Elliott takes $1B stake in BioMarin: report
Nov 8, 2023 8:25am
Catalent poaches Lonza's David McErlane to head up biologics
Sep 18, 2023 4:30pm
Catalent turns to Elliott after 2023 earnings disappoint
Aug 30, 2023 9:41am
Activist Investor Elliot takes major stake in Catalent: report
Jul 21, 2023 9:20am
Trade union resists potential Bayer breakup
Feb 13, 2023 11:05am
